Counter Press Acquisition Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPAQ research report →
Price Chart
About the company
Counter Press Acquisition Corporation (CPAQ) currently has no active business operations of its own. Its primary objective is to identify and execute a strategic business combination. This could take various forms, including a merger, acquisition of assets or shares, recapitalization, or reorganization, with an existing operating business.
- CEO
- Paul Matthew Conway
- IPO
- 2022
- HQ
- Lake Success, NY, US
Get TickerSpark's AI analysis on CPAQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $95.54M
- P/E
- 0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.00
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- +0.0%
- Gross Profit
- +0.0%
- Net Income
- +0.0%
- EPS
- +0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $10.80
- 52W Low
- $9.91
- 50D MA
- $10.30
- 200D MA
- $10.12
- Beta
- 0.00
- RSI (14)
- 71
- Avg Volume
- 39.09K
No earnings-call transcripts are available for CPAQ yet.
- Free Float
- 52.5%
- Shares Outstanding
- 9.25M
- Float Shares
- 4.86M
of shares held by institutions
32 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 27, 23 | Beryl Capital Partners II LP | other | 771,932 |
| Nov 14, 22 | Beryl Capital Partners II LP | other | 0 |
| Feb 8, 22 | Conway Paul Matthew | other | 2,156,250 |
| Feb 8, 22 | Conway Paul Matthew | other | 2,156,250 |
| Feb 8, 22 | Kalt Michael | other | 2,156,250 |
| Feb 8, 22 | Uhrman Julie | other | 0 |
| Feb 8, 22 | Counter Press Sponsor LLC | other | 2,156,250 |
| Feb 8, 22 | Friedman Andrew Earl | other | 0 |
| Feb 8, 22 | FRANKEL RANDY WILLIAM | other | 2,156,250 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CPAQ coverage
Recent articles, reports, and earnings notes.
No research on CPAQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CPAQ report →